An in-vitro method for comparative analysis of aspiration catheter tracking performance
Interventional Neuroradiology · 2026
DOI: 10.1177/15910199241278993 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Interventional Neuroradiology, 2026. Verfasst von Fritz Wodarg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Radiology and Neuroradiology Department, University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Thrombectomy, Catheters, Ischemic Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Johnson & Johnson.
Abstract (Originalsprache)
Background and purpose Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) relies on efficient tracking of aspiration catheters through complex vascular anatomies. Differences in catheter design lead to variation in tracking performance which may only become apparent after use in patients. We developed an in-vitro methodology for evaluating aspiration catheter performance under a variety of pre-defined circumstances, that can be used during catheter development for design optimization.
Methods
Validation of the in-vitro methodology involved testing four large bore aspiration catheters on recreated challenging vascular access routes derived from patient angiograms. Two experienced neurointerventionalists conducted the tests under controlled physiological and procedural conditions. Each catheter design was evaluated across 30 unique anatomy-procedural set-up combinations. A fifth, prototype large bore catheter was evaluated by trained engineers to assess the applicability of the in-vitro test.
Results
Results from statistical analysis using a general linear model demonstrated the methodology's effectiveness in detecting significant tracking differences among catheter designs ( p < 0.01). Minimal inter-operator variability was observed ( p = 0.304), while procedural techniques significantly influenced tracking performance ( p < 0.01). The tortuosity of the arterial access route notably impacted catheter performance ( p < 0.01), with anatomical features revealing varying degrees of influence on desirable and undesirable catheter design aspects.
Conclusion
We successfully developed a test methodology for evaluating the trackability of large bore aspiration catheters intended for treating acute ischemic stroke with large vessel occlusions. This methodology offers a robust approach to pre-clinical design assessment, utilizing anatomical models that simulate real-world vascular challenges to enhance catheter optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiology and Neuroradiology Department, University Hospital Schleswig-Holstein, Kiel, Germany.
- Medical Affairs Department, Cerenovus, Irvine, CA, USA.
- Radiology and Neuroradiology Department, Beaumont Hospital, Dublin, Ireland.
- Research and Development Department, Cerenovus, Ballybrit, Galway, Ireland.
- Medical Affairs Department, Cerenovus, Ballybrit, Galway, Ireland.
ORCID-Profile: Fritz Wodarg, Patrick Brouwer, Sarah Power
Förderung
- Johnson & Johnson
Zitieren
APA
Wodarg, F., Brouwer, P., Power, S., Gilvarry, M., Mirza, M., Conlon, R., Johnson, S., & McCarthy, R. (2026). An in-vitro method for comparative analysis of aspiration catheter tracking performance. Interventional Neuroradiology. https://doi.org/10.1177/15910199241278993
Vancouver
Wodarg F, Brouwer P, Power S, Gilvarry M, Mirza M, Conlon R, et al. An in-vitro method for comparative analysis of aspiration catheter tracking performance. Interventional Neuroradiology. 2026. doi:10.1177/15910199241278993
BibTeX
@article{Wodarg2026,
author = {Wodarg, Fritz and Brouwer, Patrick and Power, Sarah and Gilvarry, Michael and Mirza, Mahmood and Conlon, Richard and Johnson, Sarah and McCarthy, Ray},
title = {An in-vitro method for comparative analysis of aspiration catheter tracking performance},
journal = {Interventional Neuroradiology},
year = {2026},
doi = {10.1177/15910199241278993}
}
EUVIMED